KMR Group Study Assesses BioPharma Clinical Productivity

CHICAGO, Illinois, October 12, 2011 KMR GROUP, a firm specializing on biopharmaceutical R&D performance, is pleased to announce their upcoming Clinical Development Productivity Study. Based on prior rounds, the study will provide participating companies with a comprehensive analysis of how productive they are relative to their peers while highlighting a key set of characteristics that best explain why some companies are more productive than others.

With a growing strain on clinical resources, companies face increasing pressure to reduce costs while increasing efficiency and obtaining reliable trial results. The study will illuminate the practices that are proving productive, while also assessing trends in outsourcing, geography and cycle times which all play a pivotal role in effective clinical development organizations.

A robust set of metrics that incorporate cost, staff, outputs and cycle time performance will be used. Each area within Clinical Development will be assessed, such as Clinical Operations, Data Management, and Biostatistics. The results will help companies focus their decision-making on the factors that have the most direct effect on performance.

“Companies want to know how they compare to their peers as well as which areas have the most opportunity for improvement. The Clinical Development Productivity Study will not only answer these questions, but also will identify best practices within the industry and provide actionable customized results for each company. We feel this type of analysis cannot be obtained elsewhere and we are excited to be conducting this study again,” commented Linda Martin, Principal of KMR Group.

Companies interested in participating are encouraged to contact KMR.

For further information contact:

Linda Martin, Principal

Tel: +1 (312) 795-0400

Email: lmartin@kmrgroup.com

About KMR

KMR has been working exclusively in the biopharmaceutical R&D industry since the early 1990s. KMR is a leader in benchmarking, analytics and performance management. With an exclusive focus on biopharmaceutical R&D and unrivaled commitment to data quality, KMR provides industry with the experience and knowledge to produce clear and uncompromising results in the form of reports, tools and presentations. We use our extensive, unparalleled datasets and experience within the industry to add value to the most pressing business questions. Please visit our website at http://kmrgroup.com

MORE ON THIS TOPIC